GL1X · GenesisL1 explorer

MolNFT v1 · #117557 · protein

Kcsa T75G in the conductive state

5EBL · Antibody Fab fragment light chain: “Kcsa T75G in the conductive state”. X-ray diffraction, 3 ligands (F09, DGA, K), 6 pockets (best druggability 0.67). MolNFT v1 #117557 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5EBL
Type
protein
Length
534 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Antibody Fab fragment light chain; PH-gated potassium channel kcsa
UniProt
P0A334
Ligands
F09, DGA, K
Pockets
6 · best druggability 0.67

Structure

x-ray diffraction · 3 distinct chains · 18% helix, 40% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAntibody Fab fragment light chainprotein2194% helix, 50% strand—
BAntibody Fab fragment light chainprotein2126% helix, 50% strand—
CPH-gated potassium channel kcsaprotein10374% helix, 0% strandP0A334

Ligands and binding sites

  • F09 · Nonan-1-ol · ligand · chains A, C
  • DGA · Diacyl glycerol · ligand · chains C
  • K · Potassium ion · metal · 6 copies · chains C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17400.670.7565empty
2750.490.8415empty
3640.490.8416empty
41570.480.7736empty
5600.480.8522empty

Interfaces

3 interfaces between chains.

  • A–B · 1855 Ų buried · 18 hydrogen bonds · protein-protein
  • A–C · 456 Ų buried · 11 hydrogen bonds · protein-protein
  • B–C · 434 Ų buried · 10 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 5EBL · KcsA T75G in the Conductive State · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.